FDA Review
The latest news about FDA Review: headlines, AI summaries and the full story from every source.
- Capricor Therapeutics Updates Deramiocel BLA Timeline and Manufacturing Validation Goals
- Four High-Risk Stocks With Potential for Significant Returns
- AstraZeneca's Tozorakimab Shows Strong Results in COPD Trials
- PolyPid Reports Q2 2026 Earnings, Highlights FDA Priority Review and Partnership with Azurity
- Pomerantz Law Firm Investigates Potential Securities Fraud at Disc Medicine, Inc.
- Anika Therapeutics Q1 2026 Earnings Call Summary
- Ionis (IONS) Reports Q4 2025 Earnings with Revenue Growth and Guidance on TRYNGOLZA
- Pomerantz Law Firm Investigates Disc Medicine, Inc. for Potential Securities Fraud